Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) revealed today that it has entered into an agreement with the European Commission for the supply of COVID-19 vaccine. As per the agreement, Pfizer-BioNTech will provide 200 million doses of their ‘90% effective’